Annals of Oncology

News:

General decline of cancer incidence in US
Ann Oncol 11: 903.
[PDF] [Request Permissions]

France first in health care
Ann Oncol 11: 903.
[PDF] [Request Permissions]

France and Council of Europe against gene-patenting law
Ann Oncol 11: 903-904.
[PDF] [Request Permissions]

Task force on German fraud disillusioned
Ann Oncol 11: 904.
[PDF] [Request Permissions]

A row on euthanasia goes on while popular support increases
Ann Oncol 11: 904-905.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 11: 905.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 11: 905-907.
[PDF] [Request Permissions]

Book reviews:

J. Armitage

Book review
Ann Oncol 11: 908.
[PDF] [Request Permissions]

R. Orecchia

Book review
Ann Oncol 11: 1072.
[PDF] [Request Permissions]

Editorials:

N. Gray and P. Boyle

The regulation of tobacco and tobacco smoke
Ann Oncol 11: 909-914.
[PDF] [Request Permissions]

M. Michael and J. R. Zalcberg

The optimal 5-fluorouracil regimen for the adjuvant therapy of colon cancer: Where to from here?
Ann Oncol 11: 915-918.
[PDF] [Request Permissions]

C. J. A. Punt

‘Hold the Mayo’: Solid facts or pulp fiction?
Ann Oncol 11: 919-920.
[PDF] [Request Permissions]

C. Williams

QUOROM — another step forwards
Ann Oncol 11: 921-922.
[PDF] [Request Permissions]

P. G. Casali, L. Licitra, and P. Bruzzi

QUOROM and the search for an updated ‘clinical method’ in the era of evidence-based medicine
Ann Oncol 11: 923-925.
[PDF] [Request Permissions]

Reviews:

A. J. M. Ferreri, M. Reni, and E. Villa

Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trials
Ann Oncol 11: 927-937.
[Abstract] [PDF] [Request Permissions]

P. M. Ellis

Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature
Ann Oncol 11: 939-945.
[Abstract] [PDF] [Request Permissions]

Original articles:

D. J. Kerr, R. Gray, C. McConkey, J. Barnwell, and for the QUASAR Colorectal Cancer Study Group

Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: Non-randomised comparison of weekly versus four-weekly schedules — less pain, same gain
Ann Oncol 11: 947-955.
[Abstract] [PDF] [Request Permissions]

F. Levi, L. Randimbison, V.-C. Te, S. Franceschi, and C. La Vecchia

Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993
Ann Oncol 11: 957-963.
[Abstract] [PDF] [Request Permissions]

A. Baars, A. M. E. Claessen, A. J. M. van den Eertwegh, H. E. Gall, A. G. M. Stam, S. Meijer, G. Giaccone, C. J. L. M. Meijer, R. J. Scheper, J. Wagstaff, J. B. Vermorken, and H. M. Pinedo

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients
Ann Oncol 11: 965-970.
[Abstract] [PDF] [Request Permissions]

P. Stone, A. Richardson, E. Ream, A. G. Smith, D. J. Kerr, N. Kearney, and on behalf of the Cancer Fatigue Forum

Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey
Ann Oncol 11: 971-975.
[Abstract] [PDF] [Request Permissions]

C. Sessa, G. Capri, L. Gianni, F. Peccatori, G. Grasselli, J. Bauer, M. Zucchetti, L. Viganò, A. Gatti, C. Minoia, P. Liati, S. Van den Bosch, A. Bernareggi, G. Camboni, and S. Marsoni

Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
Ann Oncol 11: 977-983.
[Abstract] [PDF] [Request Permissions]

O. Pagani, C. Sessa, F. Nolè, D. Crivellari, D. Lombardi, B. Thürlimann, D. Hess, M. Borner, J. Bauer, G. Martinelli, R. Graffeo, M. Zucchetti, M. D'Incalci, and A. Goldhirsch

Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study
Ann Oncol 11: 985-991.
[Abstract] [PDF] [Request Permissions]

G. Krajnik, A. Mohn-Staudner, J. Thaler, R. Greil, S. Schmeikal, F. Marhold, J. Deutsch, P. Preiss, R. Malayeri, C. Schäfer-Prokop, W. Wein, H. Huber, R. Pirker, and for the Austrian Association for the Study of Lung Cancer(AASLC)

Vinorelbine—gemcitabine in advanced non-small-cell lung cancer (NSCLC): An AASLC phase II trial
Ann Oncol 11: 993-998.
[Abstract] [PDF] [Request Permissions]

G. Harrison, S. Richards, S. Lawson, P. Darbyshire, R. Pinkerton, R. Stevens, A. Oakhill, O. B. Eden, and on behalf of the MRC Childhood Leukaemia Working Party

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
Ann Oncol 11: 999-1006.
[Abstract] [PDF] [Request Permissions]

A. Z. S. Rohatiner, R. Bassan, R. Raimondi, J. A. L. Amess, S. Arnott, A. Personen, F. Rodeghiero, T. Barbui, M. J. Bradburn, M. Carter, and T. A. Lister

High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia
Ann Oncol 11: 1007-1015.
[Abstract] [PDF] [Request Permissions]

E. Bajetta, N. Zilembo, E. Bichisao, A. Martinetti, R. Buzzoni, P. Pozzi, P. Bidoli, L. Ferrari, and L. Celio

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
Ann Oncol 11: 1017-1022.
[Abstract] [PDF] [Request Permissions]

N. Botwood, R. James, C. Vernon, and P. Price

Raltitrexed (‘Tomudex’) and radiotherapy can be combined as postoperative treatment for rectal cancer
Ann Oncol 11: 1023-1028.
[Abstract] [PDF] [Request Permissions]

T. Safra, F. Muggia, S. Jeffers, D. D. Tsao-Wei, S. Groshen, O. Lyass, R. Henderson, G. Berry, and A. Gabizon

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m²
Ann Oncol 11: 1029-1033.
[Abstract] [PDF] [Request Permissions]

J. B. Vermorken, A. Kobierska, B. Chevallier, F. Zanaboni, A. Pawinski, G. Bolis, and for the EORTC Gynecological Cancer Cooperative group

A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin
Ann Oncol 11: 1035-1040.
[Abstract] [PDF] [Request Permissions]

D. Lombardi, M. D. Magri, D. Crivellari, S. Spazzapan, C. Paolello, M. De Cicco, V. Di Lauro, C. Scuderi, and A. Veronesi

Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer
Ann Oncol 11: 1041-1043.
[Abstract] [PDF] [Request Permissions]

E. Maiello, V. Gebbia, F. Giuliani, G. Paoletti, N. Gebbia, S. Cigolari, S. Fortunato, T. Pedicini, N. Borsellino, M. Lopez, G. Colucci, and on behalf of the Southern Italy Oncology Group (GOIM)

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
Ann Oncol 11: 1045-1051.
[Abstract] [PDF] [Request Permissions]

S. Cascinu, V. Catalano, C. Aschele, S. Barni, D. Debernardis, L. Gallo, R. Bandelloni, M. P. Staccioli, A. M. Baldelli, A. Brenna, A. Valenti, P. Muretto, and G. Catalano

Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil—leucovorin combination
Ann Oncol 11: 1053-1056.
[Abstract] [PDF] [Request Permissions]

M. Colleoni, I. Minchella, G. Mazzarol, F. Nolè, G. Peruzzotti, A. Rocca, G. Viale, L. Orlando, G. Ferretti, G. Curigliano, P. Veronesi, M. Intra, and A. Goldhirsch

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors
Ann Oncol 11: 1057-1059.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

S. L. Vanhees, R. Paridaens, and J. F. Vansteenkiste

Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: Case report and literature review
Ann Oncol 11: 1061-1065.
[Abstract] [PDF] [Request Permissions]

M. S. Elisaf, K. Nakou, G. Liamis, and N. A. Pavlidis

Tamoxifen-induced severe hypertriglyceridemia and pancreatitis
Ann Oncol 11: 1067-1069.
[Abstract] [PDF] [Request Permissions]

Letter to the editor:

D. Tassinari, V. Arcangeli, I. Panzini, S. Sartori, L. Gianni, and A. Ravaioli

Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?
Ann Oncol 11: 1071.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.